Amino Acid Supplementation in Recovery From Severe Burns
NCT ID: NCT01618630
Last Updated: 2018-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2012-05-31
2017-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will prospectively enroll 40 children with ≥30% of their total body surface area (TBSA) burned. The age range will be 7-17 years. Children will be recruited from Shriners Hospitals for Children (SHC)-Galveston. Burned children will be randomized to undergo an exercise program in combination with daily intake of EAA (n=20) or a placebo drink (n=20). The exercise program and daily intake of AA will begin within the first week of discharge from the burn ICU (approximately 1-3 months post burn, when the patient's wounds are 95% healed). The definition of 95% healed is 7 days after the final autografting procedure. We anticipate enrolling 10 children per year for 4 years. Only children meeting the inclusion and exclusion criteria specified in the Human Subjects Section will be enrolled.
Nutritional Supplement: The nutritional supplement will be administered at a dose of 0.18 g/kg body weight of amino acids two times per day with the following composition: 3% histidine, 9% isoleucine, 36% leucine, 17% lysine, 4% methionine, 5% phenylalanine, 10% threonine, 7% valine, and 10% arginine. The dose and choice of amino acids is based on our preliminary data. Each dose is about 0.03 g/kg body weight higher than what has been shown effective in adults, as children have higher protein needs. We have shown that only EAA are needed to affect muscle protein synthesis and lean mass. Thus the amount given (g or kcal) can be restricted. As in our preliminary studies, we will include arginine in the EAA mixture, since arginine may have unique anabolic effects (55; 86). Placebo will consist of a mixture of inert components (sucralose and other pharmaceutical excipients). The supplement will be taken in two daily doses in the form of drinks (total daily dose of i.e., 0.30 g/kg body weight total per day), and intake recorded in a diary. The first dose will be taken between breakfast and lunch, and the second between lunch and dinner. For the children exercising before lunch, the first dose of EAA will be ingested immediately after exercise. Correspondingly, for children exercising after lunch, the second EAA dose of the day will be ingested immediately after exercise. If the child forgets to take one of the drinks during the day, he/she may take the second one between dinner and bedtime. During the weekends, parents/caregivers are instructed to take the dosage around the same time.
Data Analysis and Interpretation. To determine effects of amino acids on fat and muscle lipid stores, changes from pre- to post intervention in the two groups will be compared using ANCOVA. From the preliminary data, we expect that amino acids will decrease liver and plasma lipids.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EAA Supplementation + Exercise Training
Drink an amino acid supplementation during exercise training.
EAA Supplementation + Exercise Training
Amino acids in drinks between meals for exercise training period.
Placebo + Exercise Training
Drink a placebo supplementation during exercise training.
Placebo + Exercise Training
Placebo supplementation as drinks in between meals for exercise training period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EAA Supplementation + Exercise Training
Amino acids in drinks between meals for exercise training period.
Placebo + Exercise Training
Placebo supplementation as drinks in between meals for exercise training period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 7-17 years old
3. Body weight \>20 kg (based on blood requirements)
4. ≥30% Total Body Surface Area (TBSA)
5. Wounds 95% healed
Exclusion Criteria
2. Multiple fractures
3. History of Cancer in the last 5 years
4. Diabetes Mellitus
5. Bilirubin \> 3 mg/dl
6. Associated head injuries requiring specific therapy
7. Associated injuries to chest or abdomen requiring surgery
8. Serum creatinine \> 3 mg/dl after fluid resuscitation
9. Receipt of any experimental drug other than the ones supplied within two months of this study
10. Any metal in body including rods, cardiac defibrillator, pacemakers, etc
11. Orthopedic casting which would prevent placement of patient in MRI machine
12. Hepatitis
13. Abnormal EKG
14. Electrical burns
15. Patients unable to lie still without heavy sedation will be excluded from MRI portion.
7 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shriners Hospitals for Children
OTHER
The University of Texas Medical Branch, Galveston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oscar E Suman, PhD
Role: PRINCIPAL_INVESTIGATOR
UTMB, Shriners Hospitals for Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shriners Hospitals for Children
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-048
Identifier Type: -
Identifier Source: org_study_id